Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Oxypro
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxypro 10mg modified-release tablets
0407020ADBSABAF
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 16,733 |
|
Oxypro 5mg modified-release tablets
0407020ADBSAAAK
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 12,984 |
|
Oxypro 20mg modified-release tablets
0407020ADBSADAG
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 12,639 |
|
Oxypro 30mg modified-release tablets
0407020ADBSAEAR
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 6,870 |
|
Oxypro 40mg modified-release tablets
0407020ADBSAFAH
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 6,255 |
|
Oxypro 15mg modified-release tablets
0407020ADBSACAS
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 5,615 |
|
Oxypro 60mg modified-release tablets
0407020ADBSAGAQ
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 2,471 |
|
Oxypro 80mg modified-release tablets
0407020ADBSAHAI
|
Oxypro | Oxycodone hydrochloride | Central Nervous System | 1,614 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.